Commentary: Role of Bone-Modifying Agents in Metastatic Breast Cancer

Tekijä Hortobagyi, Gabriel N.
Julkaistu 2011

Toward Individualized Breast Cancer Therapy: Translating Biological Concepts to the Bedside

Tekijä Hortobagyi, Gabriel N.
Julkaistu 2012

Everolimus Plus Exemestane for the Treatment of Advanced Breast Cancer: A Review of Subanalyses from BOLERO-2()

Tekijä Hortobagyi, Gabriel N.
Julkaisussa Neoplasia (2015)

Ribociclib for the first-line treatment of advanced hormone receptor-positive breast cancer: a review of subgroup analyses from the MONALEESA-2 trial

Tekijä Hortobagyi, Gabriel N.
Julkaisussa Breast Cancer Res (2018)

Bernard Fisher: A Pioneer Moves On

Tekijä Hortobágyi, Gabriel N.
Julkaisussa Oncologist (2019)

Interpreting Cancer Biology: Refining Our Therapeutic Algorithm in Breast Cancer

Tekijä Hortobágyi, Gabriel, Conte, Pierfranco
Julkaistu 2013

Inflammatory breast cancer: Clinical progress and the main problems that must be addressed

Tekijä Giordano, Sharon H, Hortobagyi, Gabriel N
Julkaistu 2003

Prognostic molecular markers in early breast cancer

Tekijä Esteva, Francisco J, Hortobagyi, Gabriel N
Julkaistu 2004

Fingerprinting Lymph Node Metastases

Tekijä Symmans, W. Fraser, Hortobagyi, Gabriel N.
Julkaistu 2008

Dual human epidermal growth factor receptor 2 blockade for the treatment of HER2-positive breast cancer

Tekijä Alvarez, Ricardo H., Hortobagyi, Gabriel N.
Julkaistu 2013

Indirect Evaluation of Bone Saturation with Zoledronic Acid After Long‐Term Dosing

Tekijä Hortobagyi, Gabriel N., Zheng, Ming, Mohanlal, Ramon
Julkaisussa Oncologist (2018)

CDK4/6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: Are we at the finish line?

Tekijä Yam, Clinton, Hung, Mien-Chie, Hortobagyi, Gabriel N.
Julkaisussa Oncotarget (2018)

Hot Flashes: A Review of Pathophysiology and Treatment Modalities

Tekijä Morrow, Phuong Khanh H., Mattair, Danielle N., Hortobagyi, Gabriel N.
Julkaistu 2011

Impact of Diabetes Mellitus on Complications and Outcomes of Adjuvant Chemotherapy in Older Patients With Breast Cancer

Tekijä Srokowski, Tomasz P., Fang, Shenying, Hortobagyi, Gabriel N., Giordano, Sharon H.
Julkaistu 2009

Overweight, Obesity, Diabetes, and Risk of Breast Cancer: Interlocking Pieces of the Puzzle

Tekijä La Vecchia, Carlo, Giordano, Sharon H., Hortobagyi, Gabriel N., Chabner, Bruce
Julkaistu 2011

First-cycle absolute neutrophil count can be used to improve chemotherapy-dose delivery and reduce the risk of febrile neutropenia in patients receiving adjuvant therapy: a validat...

Tekijä Rivera, Edgardo, Haim Erder, M, Fridman, Moshe, Frye, Debra, Hortobagyi, Gabriel N
Julkaistu 2003

Prognosis of Women With Metastatic Breast Cancer by HER2 Status and Trastuzumab Treatment: An Institutional-Based Review

Tekijä Dawood, Shaheenah, Broglio, Kristine, Buzdar, Aman U., Hortobagyi, Gabriel N., Giordano, Sharon H.
Julkaistu 2010

Gemcitabine Overcomes Erlotinib Resistance in EGFR-Overexpressing Cancer Cells through Downregulation of Akt

Tekijä Bartholomeusz, Chandra, Yamasaki, Fumiyuki, Saso, Hitomi, Kurisu, Kaoru, Hortobagyi, Gabriel N., Ueno, Naoto T.
Julkaistu 2011

Role of Epidermal Growth Factor Receptor in Breast Cancer

Tekijä Masuda, Hiroko, Zhang, Dongwei, Bartholomeusz, Chandra, Doihara, Hiroyoshi, Hortobagyi, Gabriel N., Ueno, Naoto T.
Julkaistu 2012

John Mendelsohn: A visionary scientist, oncologist and leader

Tekijä Kumar, Rakesh, Murad, Ferid, Bogler, Oliver, O'Malley, Bert W., Hortobagyi, Gabriel N.
Julkaisussa Genes Cancer (2019)